Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
12.74
+0.16 (1.31%)
At close: Apr 28, 2026, 4:00 PM EDT
12.89
+0.16 (1.22%)
After-hours: Apr 28, 2026, 6:39 PM EDT
Amneal Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 4,062 | 3,961 | 2,454 | 1,861 | 301 | 715 | |
| Market Cap Growth | 85.72% | 61.41% | 31.88% | 517.29% | -57.87% | 6.05% | |
| Enterprise Value | 6,465 | 6,511 | 5,081 | 4,434 | 2,989 | 3,372 | |
| Last Close Price | 12.73 | 12.60 | 7.92 | 6.07 | 1.99 | 4.79 | |
| PE Ratio | 57.89 | 54.97 | - | - | - | 67.35 | |
| Forward PE | 12.77 | 15.04 | 11.69 | 11.92 | 2.71 | 5.65 | |
| PS Ratio | 1.35 | 1.31 | 0.88 | 0.78 | 0.14 | 0.34 | |
| PB Ratio | 681.28 | 664.26 | -55.10 | 30.35 | 1.44 | 1.86 | |
| P/FCF Ratio | 16.85 | 16.43 | 10.45 | 6.23 | 18.49 | 3.75 | |
| P/OCF Ratio | 11.95 | 11.65 | 8.32 | 5.38 | 4.63 | 2.96 | |
| PEG Ratio | - | 0.51 | 0.51 | 0.51 | 0.18 | 0.66 | |
| EV/Sales Ratio | 2.14 | 2.16 | 1.82 | 1.85 | 1.35 | 1.61 | |
| EV/EBITDA Ratio | 10.03 | 10.11 | 8.69 | 9.05 | 6.79 | 7.49 | |
| EV/EBIT Ratio | 15.37 | 15.48 | 14.59 | 17.03 | 14.94 | 15.57 | |
| EV/FCF Ratio | 26.81 | 27.00 | 21.64 | 14.84 | 183.29 | 17.67 | |
| Debt / Equity Ratio | 450.96 | 450.96 | -58.22 | 44.87 | 13.62 | 7.52 | |
| Debt / EBITDA Ratio | 4.06 | 4.06 | 4.31 | 5.43 | 6.15 | 6.15 | |
| Debt / FCF Ratio | 11.15 | 11.15 | 11.05 | 9.21 | 174.50 | 15.13 | |
| Net Debt / Equity Ratio | 402.92 | 402.92 | -55.70 | 43.34 | 13.49 | 6.87 | |
| Net Debt / EBITDA Ratio | 3.73 | 3.73 | 4.24 | 5.42 | 6.40 | 5.86 | |
| Net Debt / FCF Ratio | 9.96 | 9.96 | 10.57 | 8.89 | 172.79 | 13.82 | |
| Asset Turnover | 0.84 | 0.84 | 0.80 | 0.66 | 0.57 | 0.53 | |
| Inventory Turnover | 3.10 | 3.10 | 2.98 | 2.77 | 2.79 | 2.67 | |
| Quick Ratio | 1.39 | 1.39 | 0.82 | 0.87 | 1.10 | 1.39 | |
| Current Ratio | 2.17 | 2.17 | 1.41 | 1.63 | 1.88 | 2.25 | |
| Return on Equity (ROE) | - | - | -881.26% | -36.06% | -85.96% | 5.45% | |
| Return on Assets (ROA) | 7.32% | 7.32% | 6.24% | 4.48% | 3.23% | 3.41% | |
| Return on Invested Capital (ROIC) | 15.95% | 15.96% | 13.52% | 9.07% | 6.61% | 4.62% | |
| Return on Capital Employed (ROCE) | 15.00% | 15.00% | 14.70% | 9.90% | 6.60% | 6.60% | |
| Earnings Yield | 1.77% | 1.82% | -4.76% | -4.51% | -43.12% | 1.49% | |
| FCF Yield | 5.94% | 6.09% | 9.57% | 16.06% | 5.41% | 26.68% | |
| Buyback Yield / Dilution | -5.12% | -5.12% | -75.42% | -16.69% | 0.58% | -1.95% | |
| Total Shareholder Return | -5.12% | -5.12% | -75.42% | -16.69% | 0.58% | -1.95% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.